Voluntis: Appointment of Guillaume Floch as Chief Financial Officer of Voluntis
02 Settembre 2020 - 8:00AM
Business Wire
Regulatory News:
Voluntis (Paris:VTX) (Euronext Paris, Ticker: VTX - ISIN:
FR0004183960) announces today the appointment of Guillaume Floch as
Chief Financial Officer, following the departure of Matthieu
Plessis.
Guillaume Floch, 44 years old, has more than 20 years of
professional experience in finance, first in an audit firm, then in
the biopharmaceutical sector in financial control and then in
financial management. In particular, he held the position of Chief
Financial Officer of Hybrigenics (biotechnology) for more than 10
years, after having been Administrative and Financial Manager at
Zeneus Pharma (acquired by Cephalon). Guillaume holds a DESCF and a
MSTCF from the University of Paris V.
Pierre Leurent, CEO of Voluntis, said: "I would like to
thank Matthieu Plessis for his very effective contribution to our
activities over the last few years. We are delighted to welcome
Guillaume Floch to our team and Guillaume will bring his strong
experience in the life sciences sector to support the new stage of
the company's development, in line with our strategic roadmap".
About Voluntis
Voluntis creates digital therapeutics that empower people
suffering from chronic conditions to self- manage their treatment
every day, thus improving real-world outcomes. Combining mobile and
web apps, Voluntis’ solutions deliver personalized recommendations
to the patient and the care team so that they can, for example,
adjust treatment dosage, manage side effects or monitor symptoms.
These real-time recommendations are based on digitized clinical
algorithms. Leveraging its Theraxium technology platform, Voluntis
has designed and operates multiple digital therapeutics, especially
in diabetes and oncology. Voluntis has long-standing partnerships
with leading life science companies. Based out of Boston and Paris,
France, Voluntis is a founding member of the Digital Therapeutics
Alliance. For more information, please visit: www.voluntis.com
Mnemo : VTX - ISIN : FR0004183960
Disclaimer
This press release contains certain forward-looking statements
concerning Voluntis group and its business, including its prospects
and product candidate development. Such forward-looking statements
are based on assumptions that Voluntis considers to be reasonable.
However, there can be no assurance that the estimates contained in
such forward-looking statements will be verified, which estimates
are subject to numerous risks including the risks set forth in the
reference document of Voluntis registered with the French Financial
Markets Authority (Autorité des Marchés Financiers) under number
R.19-013 on April 26, 2019 (a copy of which is available on
www.voluntis.com) and to the development of economic conditions,
financial markets and the markets in which Voluntis operates. The
forward-looking statements contained in this press release are also
subject to risks not yet known to Voluntis or not currently
considered material by Voluntis. The occurrence of all or part of
such risks could cause actual results, financial conditions,
performance or achievements of Voluntis to be materially different
from such forward-looking statements. Voluntis expressly declines
any obligation to update such forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200901005906/en/
ACTUS Media relations Vivien Ferran vferran@actus.fr +33 (0)1 53 67 36 34
ACTUS Investor relations Thomas Segouin tsegouin@actus.fr +33 (0)1 53 67 36 75
Voluntis Directeur Administratif et Financier Guillaume
Floch investisseurs@voluntis.com +33 (0)1 41 38 39 20